GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Paragon Care Ltd (FRA:PXS) » Definitions » EV-to-EBITDA

Paragon Care (FRA:PXS) EV-to-EBITDA : 20.75 (As of Sep. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Paragon Care EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Paragon Care's enterprise value is €572 Mil. Paragon Care's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €28 Mil. Therefore, Paragon Care's EV-to-EBITDA for today is 20.75.

The historical rank and industry rank for Paragon Care's EV-to-EBITDA or its related term are showing as below:

FRA:PXS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3.02   Med: 8.97   Max: 20.94
Current: 20.94

During the past 13 years, the highest EV-to-EBITDA of Paragon Care was 20.94. The lowest was -3.02. And the median was 8.97.

FRA:PXS's EV-to-EBITDA is ranked worse than
82.35% of 85 companies
in the Medical Distribution industry
Industry Median: 9.1 vs FRA:PXS: 20.94

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-26), Paragon Care's stock price is €0.25. Paragon Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.005. Therefore, Paragon Care's PE Ratio (TTM) for today is 50.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Paragon Care EV-to-EBITDA Historical Data

The historical data trend for Paragon Care's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paragon Care EV-to-EBITDA Chart

Paragon Care Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.43 6.59 11.15 7.11 21.45

Paragon Care Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.15 - 7.11 - 21.45

Competitive Comparison of Paragon Care's EV-to-EBITDA

For the Medical Distribution subindustry, Paragon Care's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paragon Care's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Paragon Care's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Paragon Care's EV-to-EBITDA falls into.



Paragon Care EV-to-EBITDA Calculation

Paragon Care's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=572.063/27.571
=20.75

Paragon Care's current Enterprise Value is €572 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paragon Care's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paragon Care  (FRA:PXS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Paragon Care's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.25/0.005
=50.00

Paragon Care's share price for today is €0.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paragon Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Paragon Care EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Paragon Care's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Paragon Care Business Description

Traded in Other Exchanges
Address
77-97 Ricketts Road, Mount Waverley, VIC, AUS, 3149
Paragon Care Ltd is a medical device company. It is a provider of medical equipment, devices, and consumables to the healthcare market. The company provides solutions to various healthcare markets Aged care; Hospital and Acute care; Primary Care; Eye Care; Storage Solutions; and E-Health. The group is organized into four operating segments: Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology and the majority of its revenues are generated from services and technology.